Hypertonic saline for bronchiolitis in infants

Insights

Inhaled hypertonic saline may benefit hospitalized infants with bronchiolitis longer than three days. However, current evidence does not support its routine use in all acute care settings for this common childhood illness.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Infectious Diseases

Background:

  • Bronchiolitis is a common viral respiratory infection in infants, frequently requiring hospitalization.
  • Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis.
  • Hospitalization for bronchiolitis is a significant concern in pediatric acute care.

Purpose of the Study:

  • To evaluate the efficacy of inhaled hypertonic saline for bronchiolitis management in pediatric patients.
  • To determine if hypertonic saline is recommended for children in the acute care setting.

Main Methods:

  • Review of recent studies on nebulized hypertonic saline for bronchiolitis.
  • Analysis of treatment outcomes in hospitalized infants.

Main Results:

  • Studies on hypertonic saline for bronchiolitis have yielded conflicting results.
  • Potential benefits observed in infants hospitalized for over three days.
  • Insufficient evidence for widespread recommendation in all acute care settings.

Conclusions:

  • Nebulized hypertonic saline may have a role in managing hospitalized bronchiolitis patients beyond three days.
  • Routine use of hypertonic saline in acute care for bronchiolitis is not currently recommended due to limited demonstrated benefit.
  • Further research may clarify specific indications for hypertonic saline therapy in pediatric bronchiolitis.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
674
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
5.7K